Background: As increasing numbers of older people are listed for solid organ transplantation, there is an urgent need to better understand how aging modifies alloimmune responses. Here, we investigated whether aging impairs the ability of donor dendritic cells or recipient immunity to prime alloimmune responses to organ transplantation.
Introduction
During the last decade, increasing numbers of people over 65 years of age are currently waiting for kidney transplants [1, 2] . Since the number of older people in our society will continue to grow and as many end stage organ disorders are associated with increased age, it is likely that an even larger number of older patients will receive solid and cellular transplants in the coming years [2, 3] .
Clinical studies have indicated that older people have a reduced immune response to infections as well as an impaired ability to reject organ allografts [4] [5] [6] [7] [8] [9] [10] [11] . Overall, it is not clear how aging alters the response to organ transplantation. Some experimental reports have indicated that reduced alloimmune responses may be due to declining cellular immunity [12] [13] [14] , while other reports have shown that increasing donor age can negatively impact allograft survival [15] . In contrast to these reports, there is evidence that aging is associated with increased chronic rejection [16] . Hence, aging may impact alloimunity via multiple effects, although it is unclear whether altered cellular alloimmunity with aging is due to impaired priming by dendritic cells (DCs) or due to defective intrinsic T cell function.
Donor DCs, recipient DCs and T cells are some of the critical cellular mediators of acute allograft rejection as defects in these cells can significantly impair the ability of recipients to reject organ transplants [17] [18] [19] . However, the impact of aging on the effect on each of these cells in the setting of allotransplantation is not fully elucidated and it is not clear if declining cellular alloimmunity with aging is due to impaired priming by DCs or defective recipient factors intrinsic or extrinsic to the T cell. Hence, the goal of the present study was to determine whether aging impairs alloimmune priming function of donor DCs, recipient DCs or T cell intrinsic alloimmune responses. We provide evidence that factors both intrinsic and extrinsic to recipient T cells are defective with aging in response to skin transplantation, however aging does not impair the ability of donor DCs to prime alloimmune responses in our experimental systems.
Results
Aged donor bone marrow derived DCs (BMDCs) exhibit similar alloimmune priming capabilities as compared to young counterparts Prior work has indicated that donor DCs are one of the main cellular activators of acute allograft rejection [20] . Hence, we examined the effect of age on the ability of BMDCs to stimulate allo-reactive splenocytes. Young C57BL/6 mice were immunized with young CBA spleen cells. Two weeks later, recipient spleen cells were harvested and stimulated ex vivo with irradiated aged (20-22 months of age) or young (2-4 months of age) CBA BMDCs. The results show that aged BMDCs induced similar production of IFN-c in allo-reactive spleen cells as compared to young BMDCs ( Figure 1A ). These results are consistent with prior work that demonstrated that aged and young allogeneic BMDCs were equally able to activate naïve T cells in vitro [21] .
To examine the role of aging on the in vivo priming capabilities of allogeneic BMDCs, aged or young CBA BMDCs were injected into young C57BL/6 mice. Two weeks later the recipient spleens were harvested and stimulated ex vivo with young, irradiated CBA spleen cells. The results demonstrate that aged donor BMDCs exhibit a similar in vivo priming ability, as measured by IFN-c produced by recipient spleen cells, compared to young counterparts ( Figure 1B ).
Splenic APCs and DCs exhibit a preserved ability to prime allogeneic T cells with aging
In the above experiments, we employed BMDCs, which were expanded ex vivo with GM-CSF. As this may have masked a defect with aging, we next performed experiments with antigen presenting cells (APCs) and DCs that were purified directly from mice, without any further ex vivo expansion. Splenic APCs and DCs purified from aged (18-20 months of age) mice exhibited a similar ability to induce allogeneic T cell proliferation and IFN-c production in vitro as compared to young cells (Figure 2A ). Furthermore, DCs purified from aged mice exhibited a similar alloimmune priming response in vivo ( Figure 2B ) as compared to young cells. Additionally, aged DCs manifested similar surface expression of MHC class II, CD40, CD54 and CD86 at rest and after culture with allogeneic T cells as compared to young DCs (data not shown).
Graft originating APCs exhibit a similar ability to prime allogeneic T cell responses and induce a similar tempo of allograft rejection with aging
To investigate whether aging influenced the ability of graft originating, donor APCs to prime alloimmune responses, aged or young C57BL/6 allografts were transplanted onto young CBA recipients. In this experimental design, all the recipient DCs and T cells are young and the experimental variable is the age of the donor APC. Two weeks later, recipient spleen cells were harvested and stimulated ex vivo with irradiated donor (i.e., C57BL/6) spleen cells. The results show that aged allografts induced similar IFN-c responses in young recipients as compared to young recipients transplanted with a young allograft ( Figure 3A) . Finally, aged C57BL/6 allografts underwent a similar tempo of allograft rejection when transplanted onto young CBA recipients as compared to young allografts transplanted onto young recipients ( Figure 3B ). In sum, these data indicate that aging does not impair the ability of donor, graft originating APCs to prime T cell responses in our experimental systems.
The aged host environment impairs the activation and expansion of transplant specific CD8 + T cells . Two days later, aged or young adoptively transferred mice received a young B6 OVA-expressing skin transplant (Act-mOVA). These mice express a membrane-bound form of OVA that is expressed under the control of b-actin promoter. This is an established minormismatched transplant model, which allows one to track the fate of graft-specific T cells in vivo [22] . Thus, in this experimental design the variable is the recipient age, which contains recipient APCs.
At various time points post transplantation, spleen cells were harvested and the cytokine function and expansion of young OTI (CD8 + ) and OTII (CD4 + ) T cells in either aged or young recipients were measured. We found that the peak expansion of young antigen specific CD8 + T cells was reduced in an aged environment as compared to a young environment ( Figure 4 ). However, young antigen specific CD8 + T cells produced similar cytokine responses for IFN-c, IL-2 and TNFa regardless of the age of the host environment ( Figure 5A ). Nevertheless, the activation status (measured by the up-regulation of CD27 and down-regulation of CD62L) of antigen specific CD8 + T cells was higher in young hosts than in aged hosts ( Figure 5B ). We noted that CD4 + T cell responses were generally a log-fold lower than CD8 + T cell responses in this experimental model and with similar responses in either an aged or young environment (data not shown). These data indicate that aging impairs the recipient host environment (containing APCs) to activate and expand antigen specific CD8 + T cell responses in vivo, although the aged host environment allows effective cytokine responses in these T cells.
The above results indicate that factors within the aged host extrinsic to the T cell impair the expansion of antigen specific CD8 + T cells. To examine if aging impaired the ability of DCs to process and present cognate peptides to antigen specific CD8 + T cells, we measured the ability of young or aged splenic DCs to activate OTI CD8 + T cells in vitro. Our results demonstrate that aged splenic DCs, cultured with OVA peptides, were able to induce a similar degree of proliferation in OTI CD8 + T cells in comparison to young splenic DCs ( Figure 6A ). We next examined the ability of aged and young splenic DCs, which were pulsed with OVA peptides and then adoptively transferred into young syngeneic recipients, to expand and activate OTI CD8 + T cells in vivo. The results demonstrate that OTI T CD8
+ T cells transferred with aged splenic DCs into young recipients exhibited a similar expansion and inflammatory cytokine response as compared to young OTI CD8 + T cells transferred with young splenic DCs into young recipients ( Figure 6B-C) .
Aging impairs T cell responses to allotransplantation
Our results above indicate that aging does not impair the ability of either donor or recipient DCs to prime transplant specific T cell responses. We next examined if aging impairs T cell alloimmune responses, by adoptively transferred magnetically purified aged or young T cells into young T cell deficient mice, which received a skin allograft two days earlier. We found that young recipients that received aged T cells manifested a slightly delayed time to allograft rejection as compared to young recipients that received young T cells ( Figure 7A ).
To examine whether aging affects recipient T cell responses primed by young, donor APCs in vivo, young or aged CBA recipients were transplanted with a young C57BL/6 allograft. Two weeks post transplantation, recipient T cells were enriched and CD4 + T cells purified via magnetic sorting. The purified CD4
+ T cells, which we confirmed by flow cytometry were devoid of recipient APCs (data not shown), were subsequently stimulated ex vivo with irradiated donor spleen cells. The results show that aging significantly impaired the ability of CD4 + T cells to respond to young donor APCs as compared to young CD4 + T cells ( Figure 7B ). + DCs, purified from aged or young CBA mice, were cultured with C57BL/6 T cells and cellular proliferation and IFN-c measured. Similar results were noted in two independent experiments and with an alternate donor (C57BL/6) and recipient T cell (BALB/C) combination. B: Aged or young splenic CBA DCs were injected into C57BL/6 mice. 10 days later spleens were harvested from the groups and cultured with irradiated CBA spleen cells, and cellular proliferation and IFN-c measured. The change from T cells from mice that were not immunized is shown. There were no significant differences noted between mice injected with either young or aged allogeneic DCs. Representative data from one experiment, which was repeated with consistent results. doi:10.1371/journal.pone.0004097.g002
Finally, in vitro stimulation with allogeneic BMDCs, revealed that aged polyclonal T cells did not upregulate certain T cell activation markers, CD25 and CD28, to the same degree as young polyclonal T cells, although the upregulation of other activation markers, e.g., ICOS, was preserved with aging ( Figure 7C) . Prior work has shown that aged T cells manifest impaired IL-2 and IFNc responses in this assay [21] . In summary, the above data indicate that aging impairs T cells to respond to allostimulation.
Discussion
Aging has been associated with lower frequencies of acute allograft rejection, yet it has not been clear if such a phenotype is due to impaired donor or recipient APC priming of alloreactive T cells. Our study has provided evidence that aging impairs the ability of the recipient host environment, both intrinsic and extrinsic to the T cell, to respond to skin transplants. However, the alloimmune priming capabilities of donor APCs are preserved with aging in our experimental systems. Other work has indicated that aging augments immune priming by donor DCs [23] and our study does not exclude that aging may play important roles of the function of donor DCs, especially when DCs originate from vascularized allografts. Overall, our study indicates that aging impairs recipient immune responses to allostransplantation, whereas donor APC and DC responses remain preserved in our experimental systems.
We determined that aging also impaired the ability of the recipient host environment, extrinsic to the T cell, to expand and activate antigen specific naïve CD8 + T cells in response to skin transplantation (Figure 2 and 3B) . We directly examined whether aging led to a defective ability of recipient splenic DCs to prime and activate antigen specific T cells. In our experimental system, the antigen in this case, an OVA peptide, was also a transplant antigen. However, we did not discern that aged splenic DCs exhibited a defective ability to expand and activate antigen specific CD8 + T cells as compared to young DCs. It is not clear what factors within the aged host impair the ability of antigen specific CD8 + T cells to expand, although possibilities include heightened BCL-2 and type I interferon levels. This is because a prior study, which employed non-transplant experimental models, found that the aged host environment impaired the turnover of memory CD44 hi CD8 + T cells via heightened BCL-2 expression and higher type I interferon levels [24] . Future studies are warranted to determine the factors within the aged host environment that impair the expansion of antigen-specific, naïve CD8 + T cells. In conclusion, our study provides evidence that aging impairs recipient factors, both intrinsic and extrinsic to the T cell during transplantation. This information may provide a foundation for further mechanistic studies investigating how aging modifies alloimmunity, as well as translational studies that investigate how older people respond differently to solid organ allografts. Tcrd tm1Mom (designated as T cell deficient mice), BALB/c and B6 Act-mOVA mice were purchased from the Jackson Laboratories, Bar Harbor, ME. B6.CD45.1 + OT1 and B6.Thy1.1 + OTII mice were generously provided by Dr. Richard Flavell and Dr. Lauren Cohn, respectively (Yale University). Yale University IACUC approved the use of animals in this study. All mice were kept in pathogen free conditions. No animals were used in the study if they had evidence of skin lesions, weight loss or lymphadenopathy. Additionally, sentinel mice were regularly tested by Yale Rodent Services and found to be negative for common murine pathogens in the serum, nasopharynx and the gastrointestinal tract (pathogens tested included mouse hepatitis virus, parvovirus, mycoplasma pneumonia, sendai virus, lymphocytic choriomengitis virus, ectromelia virus, pneumonia virus and epizootic diarrhea of infant mice).
Materials and Methods

Mice
Skin transplantation
Full-thickness trunk skin was transplanted from donor mice and stapled on recipients as previously described [25] . Rejection was defined as graft necrosis .90% of the graft area.
Cell purification, and in vitro T cell cultures
The generation of BMDCs has been described in our previous work [26] . Splenic DCs were purified by positive selection (antiphycoerythrin-CD11c monoclonal antibody) using EasySep (StemCell Technologies, Vancouver, BC, Canada). Splenic APCs were purified by depleting spleen cells of T cells, using reagents from EasySep. T cells were purified via negative magnetic selection using EasySep reagents. To perform the primary mixed /well irradiated (30Gy) aged or young splenic DCs in the presence of OVA peptide at the indicated dose for 72 h. Thymidine incorporation assay was used to measure cellular proliferation according to our prior work [27] .
ELISPOT and ELISA
ELISPOT analysis was performed as per our previously published work [26] . ELISA of culture supernatants was performed using reagents from BD Biosciences (San Diego, CA), according to manufacturer's instructions. . Aged splenic DCs loaded with cognate peptide exhibit a similar ability to prime antigen specific CD8 + T cells as compared to young splenic DCs. A: Aged and young splenic DCs were cultured with OTI T cells in the presence of OVA peptide and proliferation measured. Representative from one experiment, which was repeated with similar results. B: Young hosts (N = 3/group) were adoptively transferred with young CD45.1 + OTI T cells and either young or aged splenic DCs that had been pulsed with OVA peptide (or irrelevant peptide, GP33, as a control). After 5 days, expansion of transferred young OTI T cells was assessed. Proportion of transferred T cells is shown in the box in each flow plot. Representative data from one experiment, which was repeated with similar results. C: Same experiment as B except that cytokine production by the transferred OTI T cells (gated on CD45. 
Statistical analysis
Survival analysis between groups was calculated using the Logrank method. Comparison of means was performed using a 2-tailed T-test and repeated measures using analysis of variance. All results were generated using GraphPad prism software (San Diego, CA). Statistical significance was considered a p value ,0.05.
